Farber disease: management
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Farber disease: management. Ceramidase level, Genetics, Histopathology. Fully referenced neurology checklist.
Investigations
- Ceramidase level
- Genetics
- Histopathology
Treatment
Locked: subscribe to see this section.
References
- Watts RW. A historical perspective of the glycosphingolipids and sphingolipidoses. Philos Trans R Soc Lond B Biol Sci 2003; 358:975-983.
- Kolter T, Sandhoff K. Sphingolipid metabolism diseases. Biochim Biophys Acta 2006; 1758:2057-2079.
- Ehlert K, Frosch M, Fehse N, Zander A, Roth J, Vormoor J. Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr Rheumatol Online J 2007; 5:15.
- Ekici B, Kürkçü D, Caliskan M. Farber disease: A clinical diagnosis. J Pediatr Neurosci 2012; 7:154-155.